Immunohistochemical expression of fibroblast growth factor (FGF)-2 in epilepsy-associated malformations of cortical development (MCDs)

Neuropathology

Volumn 28, Issue 4, 2008, Pages 372-381

  Sugiura, Chitose ^a   Miyata, Hajime ^a   Ueda, Manami ^a   Ohama, Eisaku ^a   Vinters, Harry V ^b   Ohno, Kousaku ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Astrocyte; Epilepsy; FGF 2; Immunohistochemistry; Malformation of cortical development (MCD)

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; TUBERIN;

ADOLESCENT; ADULT; ARTICLE; ASTROCYTE; BRAIN DEVELOPMENT; BRAIN MALFORMATION; CASE REPORT; CELL DIFFERENTIATION; CELL MATURATION; CELL NUCLEUS MEMBRANE; CHILD; CONTROLLED STUDY; CORTICAL DYSPLASIA; CYTOPLASM; EPILEPSY; FEMALE; GLIA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NEUROBLAST; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; ASTROCYTES; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CEREBRAL CORTEX; CHILD; CHILD, PRESCHOOL; EPILEPSY; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MALFORMATIONS OF CORTICAL DEVELOPMENT; MIDDLE AGED; NERVE TISSUE PROTEINS; OLIGODENDROGLIA;

EID: 44849126462     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2007.00881.x     Document Type: Article

References (64)

1. Mischel PS, Nguyen LP, Vinters HV. Cerebral cortical dysplasia associated with pediatric epilepsy. Review of neuropathologic features and proposal for a grading system. J Neuropathol Exp Neurol 1995 54:137 153.
2. Taylor DC, Falconer MA, Bruton CJ, Corsellis JA. Focal dysplasia of the cerebral cortex in epilepsy. J Neurol Neurosurg Psychiatry 1971 34:369 387.
3. Brodtkorb E, Nilsen G, Smevik O, Rinck PA. Epilepsy and anomalies of neuronal migration: MRI and clinical aspects. Acta Neurol Scand 1992 86:24 32.
4. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 1993 34:453 468.
5. Urbach H, Scheffler B, Heinrichsmeier T et al. Focal cortical dysplasia of Taylor's balloon cell type: a clinicopathological entity with characteristic neuroimaging and histopathological features, and favorable postsurgical outcome. Epilepsia 2002 43:33 40.
6. Wyllie E, Comair YG, Kotagal P, Bulacio J, Bingaman W, Ruggieri P. Seizure outcome after epilepsy surgery in children and adolescents. Ann Neurol 1998 44:740 748.
7. Palmini A, Najm I, Avanzini G et al. Terminology and classification of the cortical dysplasias. Neurology 2004 62 (Suppl 3 S2 S8.
8. Crino PB, Miyata H, Vinters HV. Neurodevelopmental disorders as a cause of seizures: neuropathologic, genetic, and mechanistic considerations. Brain Pathol 2002 12:212 233.
9. Vinters HV, Miyata H. Neuropathologic features of tuberous sclerosis. In:McLendon RE, Rosenblum MK, Bigner DD, eds. Russell and Rubinstein's Pathology of Tumors of the Nervous System, 7th edn. London:Edward Arnold, 2006 955 969.
10. Mizoguchi M, Iwaki T, Morioka T, Fukui M, Tateishi J. Abnormal cytoarchitecture of cortical dysplasia verified by immunohistochemistry. Clin Neuropathol 1998 17:100 109.
11. Yamanouchi H, Jay V, Otsubo H, Kaga M, Becker LE, Takashima S. Early forms of microtubule-associated protein are strongly expressed in cortical dysplasia. Acta Neuropathol (Berl) 1998 95:466 470.
12. Crino PB, Trojanowski JQ, Eberwine J. Internexin, MAP1B, and nestin in cortical dysplasia as markers of developmental maturity. Acta Neuropathol (Berl) 1997 93:619 627.
13. Fauser S, Becker A, Schulze-Bonhage A et al. CD34-immunoreactive balloon cells in cortical malformations. Acta Neuropathol (Berl) 2004 108:272 278.
14. Aronica E, Özbas-Gerçeker F, Redeker S et al. Expression and cellular distribution of high- and low-affinity neurotrophin receptors in malformations of cortical development. Acta Neuropathol (Berl) 2004 108:422 434.
15. Baybis M, Yu J, Lee A et al. mTOR cascade activation distinguishes tubers from focal cortical dysplasia. Ann Neurol 2004 56:478 487.
16. Miyata H, Chiang ACY, Vinters HV. Insulin signaling pathways in cortical dysplasia and TSC-tubers: tissue microarray analysis. Ann Neurol 2004 56:510 519.
17. Goldfarb M. Functions of fibroblast growth factors in vertebrate development. Cytokine Growth Factor Rev 1996 7:311 325.
18. Ornitz DM. FGFs, heparan sulfate and FGFRs: complex interactions essential for development. Bioessays 2000 22:108 112.
19. Reuss B, von Bohlen und Halbach O. Fibroblast growth factors and their receptors in the central nervous system. Cell Tissue Res 2003 313:139 157.
20. Giordano S, Sherman L, Morrison R. Multiple molecular weight forms of basic fibroblast growth factor are developmentally regulated in the rat central nervous system. Ann NY Acad Sci 1991 638:420 423.
21. Gonzalez AM, Buscaglia M, Ong M, Baird A. Distribution of basic fibroblast growth factor in the 18-day rat fetus: localization in the basement membranes of diverse tissues. J Cell Biol 1990 110:753 765.
22. Eckenstein FP, Andersson C, Kuzis K, Woodward WR. Distribution of acidic and basic fibroblast growth factors in the mature, injured and developing rat nervous system. Prog Brain Res 1994 103:55 64.
23. Gonzalez AM, Hill DJ, Logan A, Maher PA, Baird A. Distribution of fibroblast growth factor (FGF) -2 and FGF receptor-1 messenger RNA expression and protein presence in the mid-trimester human fetus. Pediatr Res 1996 39:375 385.
24. Qian X, Davis AA, Goderie SK, Temple S. FGF2 concentration regulates the generation of neurons and glia from multipotent cortical stem cells. Neuron 1997 18:81 93.
25. Dono R, Texido G, Dussel R, Ehmke H, Zeller R. Impaired cerebral cortex development and blood pressure regulation in FGF-2-deficient mice. EMBO J 1998 17:4213 4225.
26. Ortega S, Ittmann M, Tsang SH, Ehrlich M, Basilico C. Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc Natl Acad Sci USA 1998 95:5672 5677.
27. Li AJ, Suzuki S, Suzuki M, Mizukoshi E, Imamura T. Fibroblast growth factor-2 increases functional excitatory synapses on hippocampal neurons. Eur J Neurosci 2002 16:1313 1324.
28. Li Q, Stephenson D. Postischemic administration of basic fibroblast growth factor improves sensorimotor function and reduces infarct size following permanent focal cerebral ischemia in the rat. Exp Neurol 2002 177:531 537.
29. Leker RR, Soldner F, Velasco I, Gavin DK, Androutsellis-Theotokis A, McKay RD. Long-lasting regeneration after ischemia in the cerebral cortex. Stroke 2007 38:153 161.
30. Reilly JF, Kumari VG. Alterations in fibroblast growth factor receptor expression following brain injury. Exp Neurol 1996 140:139 150.
31. Liu Z, Holmes GL. Basic fibroblast growth factor is highly neuroprotective against seizure-induced long-term behavioural deficits. Neuroscience 1997 76:1129 1138.
32. Roach ES, Gomez MR, Northrup H. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol 1998 13:624 628.
33. McKinnon RD, Matsui T, Dubois-Dalcq M, Aaronson SA. FGF modulates the PDGF-driven pathway of oligodendrocyte development. Neuron 1990 5:603 614.
34. Naruse M, Nakahira E, Miyata T, Hitoshi S, Ikenaka K, Bansal R. Induction of oligodendrocyte progenitors in dorsal forebrain by intraventricular microinjection of FGF-2. Dev Biol 2006 297:262 273.
35. Bansal R, Pfeiffer SE. FGF-2 converts mature oligodendrocytes to a novel phenotype. J Neurosci Res 1997 50:215 228.
36. Goddard DR, Berry M, Kirvell SL, Butt AM. Fibroblast growth factor-2 inhibits myelin production by oligodendrocytes in vivo. Mol Cell Neurosci 2001 18:557 569.
37. Farrell MA, DeRosa MJ, Curran JG et al. Neuropathologic findings in cortical resections (including hemispherectomies) performed for the treatment of intractable childhood epilepsy. Acta Neuropathol (Berl) 1992 83:246 259.
38. Torelli S, Dell'Era P, Ennas MG et al. Basic fibroblast growth factor in neuronal cultures of human fetal brain. J Neurosci Res 1990 27:78 83.
39. Gomez-Pinilla F, Lee JWK, Cotman CW. Distribution of basic fibroblast growth factor in the developing rat brain. Neuroscience 1994 61:911 923.
40. Cepeda C, André VM, Levine MS et al. Epileptogenesis in pediatric cortical dysplasia: the dysmature cerebral developmental hypothesis. Epilepsy Behav 2006 9:219 235.
41. Joy A, Moffett J, Neary K et al. Nuclear accumulation of FGF-2 is associated with proliferation of human astrocytes and glioma cells. Oncogene 1997 14:171 183.
42. Thom M, Martinian L, Sisodiya SM et al. Mcm2 labelling of balloon cells in focal cortical dysplasia. Neuropathol Appl Neurobiol 2005 31:580 588.
43. Riva MA, Gale K, Mocchetti I. Basic fibroblast growth factor mRNA increases in specific brain regions following convulsive seizures. Brain Res Mol Brain Res 1992 15:311 318.
44. Ballabriga J, Pozas E, Planas AM, Ferrer I. bFGF and FGFR-3 immunoreactivity in the rat brain following systemic kainic acid administration at convulsant doses: localization of bFGF and FGFR-3 in reactive astrocytes, and FGFR-3 in reactive microglia. Brain Res 1997 752:315 318.
45. Gomez-Pinilla F, van der Wal EA, Cotman CW. Possible coordinated gene expressions for FGF receptor, FGF-5, and FGF-2 following seizures. Exp Neurol 1995 133:164 174.
46. Humpel C, Lippoldt A, Chadi G, Ganten D, Olson L, Fuxe K. Fast and widespread increase of basic fibroblast growth factor messenger RNA and protein in the forebrain after kainate-induced seizures. Neuroscience 1993 57:913 922.
47. Riva MA, Donati E, Tascedda F, Zolli M, Racagni G. Short- and long-term induction of basic fibroblast growth factor gene expression in rat central nervous system following kainate injection. Neuroscience 1994 59:55 65.
48. Kondratyev A, Ved R, Gale K. The effects of repeated minimal electroconvulsive shock exposure on levels of mRNA encoding fibroblast growth factor-2 and nerve growth factor in limbic regions. Neuroscience 2002 114:411 416.
49. Murashima YL, Suzuki J, Yoshii M. Developmental program of epileptogenesis in the brain of EL mice. Epilepsia 2005 46 (Suppl 5 10 16.
50. Issa RAI, Qteishat A, Mitsios N et al. Expression of basic fibroblast growth factor mRNA and protein in the human brain following ischaemic stroke. Angiogenesis 2005 8:53 62.
51. Avoli M, Bernasconi A, Mattia D, Olivier A, Hwa GG. Epileptiform discharges in the human dysplastic neocortex: in vitro physiology and pharmacology. Ann Neurol 1999 46:816 826.
52. Cepeda C, Hurst RS, Flores-Hernández J et al. Morphological and electrophysiological characterization of abnormal cell types in pediatric cortical dysplasia. J Neurosci Res 2003 72:472 486.
53. Mathern GW, Cepeda C, Hurst RS, Flores-Hernandez J, Mendoza D, Levine MS. Neurons recorded from pediatric epilepsy surgery patients with cortical dysplasia. Epilepsia 2000 41 (Suppl 6 S162 S167.
54. Mattia D, Olivier A, Avoli M. Seizure-like discharges recorded in human dysplastic neocortex maintained in vitro. Neurology 1995 45:1391 1395.
55. Palmini A, Gambardella A, Andermann F et al. Intrinsic epileptogenicity of human dysplastic cortex as suggested by corticography and surgical results. Ann Neurol 1995 37:476 487.
56. Crino PB, Duhaime AC, Baltuch G, White R. Differential expression of glutamate and GABA-A receptor subunit mRNA in cortical dysplasia. Neurology 2001 56:906 913.
57. Kerfoot C, Vinters HV, Mathern GW. Cerebral cortical dysplasia: giant neurons show potential for increased excitation and axonal plasticity. Dev Neurosci 1999 21:260 270.
58. Mikuni N, Babb TL, Ying Z et al. NMDA-receptors 1 and 2A/B coassembly increased in human epileptic focal cortical dysplasia. Epilepsia 1999 40:1683 1687.
59. White R, Hua Y, Scheithauer B, Lynch DR, Henske EP, Crino PB. Selective alterations in glutamate and GABA receptor subunit mRNA expression in dysplastic neurons and giant cells of cortical tubers. Ann Neurol 2001 49:67 78.
60. Crino PB, Jin H, Shumate MD, Robinson MB, Coulter DA, Brooks-Kayal AR. Increased expression of the neuronal glutamate transporter (EAAT3/EAAC1) in hippocampal and neocortical epilepsy. Epilepsia 2002 43:211 218.
61. André VM, Flores-Hernández J, Cepeda C et al. NMDA receptor alterations in neurons from pediatric cortical dysplasia tissue. Cereb Cortex 2004 14:634 646.
62. Miyata H, Vinters HV, Kakita A, Ohama E. Tryptophan metabolism and epileptogenicity in malformations of cortical development (MCDs) - tissue microarray immunohistochemical study on kynurenine pathway. Ann Rep Jpn Epi Res Found 2007 18:37 42 (in Japanese with English abstract).
63. Tian GF, Azmi H, Takano T et al. An astrocytic basis of epilepsy. Nat Med 2005 11:973 981.
64. Vorobyov V, Schibaev N, Kovalev G, Alzheimer C. Effects of neurotransmitter agonists on electrocortical activity in the cat kainate model of temporal lobe epilepsy and the modulatory action of basic fibroblast growth factor. Brain Res 2005 1051:123 136.